Fact Sheets

March 16, 2025 | Controlled Substances, Drug Courts, Fact Sheets, Harm Reduction, Peer Support and Recoery Services, Public Health, Public Safety, Recovery, Treatments

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) details how opioid settlement proceeds are being disbursed to state and local governments, how those governments are choosing to spend those funds, and the obstacles that can prevent these funds from helping those who have been affected by the opioid epidemic....

March 5, 2025 | Controlled Substances, Fact Sheets, Fentanyl, Harm Reduction, Public Safety, Synthetic Drugs

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) provides an overview of the sudden increase in the presence of BTMPS in the illicit drug supply and its rapid proliferation across the country, which has left drug policy experts and harm reduction specialists puzzled as to why it is in the supply and how it will affect the individuals consuming it....

October 7, 2024 | Criminal Justice, Fact Sheets, Law Enforcement, Reentry

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) provides an overview of the collateral consequences of becoming involved in the criminal justice system. Some of these consequences can include losing the right to vote, losing the right to serve on a jury, and losing the right to own a firearm, and often the barriers put in place against a charged individual and the consequences have no relation to the criminal offense. ...

October 7, 2024 | Controlled Substances, Fact Sheets, Fentanyl, Novel Psychoactive Substances, Opioids, Substance Misuse

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) discusses the emergence of  "tusi," which is also known as pink cocaine. Tusi is a group of psychedelic drugs common amongst clubgoers, dyed pink, that actually rarely contains cocaine. While tusi itself is not controlled under the Controlled Substances Act, its individual components like ketamine and fentanyl often are, and because users rarely know what is in the particular mix they are ingesting, they cannot anticipate the side effects....

July 12, 2024 | Fact Sheets, Medication Assisted Treatment (MAT), Novel Psychoactive Substances, Opioids, Recovery, Substance Misuse, Treatments

In this fact sheet the Legislative Analysis and Public Policy Association (LAPPA) details the changes to the "primary diagnosis other than OUD" regulation. The fact sheet also covers the federal regulatory scheme for methadone for OUD and explains what led SAMHSA to revise its regulations. ...

March 18, 2024 | Fact Sheets, Novel Psychoactive Substances, Opioids, Public Safety, Stimulants, Substance Misuse, Synthetic Drugs

The Legislative Analysis and Public Policy Association (LAPPA) is monitoring the emergence of novel psychoactive substances (NPS) appearing on the streets of the United States. This fact sheet, which focuses on Xylazine, was originally the second in a series that highlights these dangerous drugs. This is an update to the original version....